Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice

Toxoplasma gondii causes one of the most common protozoal diseases of humans and animals worldwide. With the aim of designing an effective vaccine against T. gondii infection, we examined the immunogenicity of a DNA vaccine expressing heat shock protein 40 (HSP40) against challenge with T. gondii (t...

Full description

Bibliographic Details
Main Authors: Li Zhong-Yuan, Lu Jing, Zhang Nian-Zhang, Elsheikha Hany M., Hou Jun-Ling, Guo Hai-Ting, Zhu Xing-Quan
Format: Article
Language:English
Published: EDP Sciences 2018-01-01
Series:Parasite
Subjects:
Online Access:https://doi.org/10.1051/parasite/2018040
_version_ 1797642831661105152
author Li Zhong-Yuan
Lu Jing
Zhang Nian-Zhang
Elsheikha Hany M.
Hou Jun-Ling
Guo Hai-Ting
Zhu Xing-Quan
author_facet Li Zhong-Yuan
Lu Jing
Zhang Nian-Zhang
Elsheikha Hany M.
Hou Jun-Ling
Guo Hai-Ting
Zhu Xing-Quan
author_sort Li Zhong-Yuan
collection DOAJ
description Toxoplasma gondii causes one of the most common protozoal diseases of humans and animals worldwide. With the aim of designing an effective vaccine against T. gondii infection, we examined the immunogenicity of a DNA vaccine expressing heat shock protein 40 (HSP40) against challenge with T. gondii (type I RH and type II Pru) strains in Kunming mice. The plasmid pVAX1-HSP40 was constructed and used to immunize mice by intramuscular injection for three sequential immunizations with two-week intervals. This immunization regimen significantly reduced parasite cyst burden in pVAX1-HSP40-immunized mice (1871.9 ± 142.3) compared with control mouse groups immunized with pVAX1 (3479.2 ± 204.4), phosphate buffered saline (3024.4 ± 212.8), or left untreated (3275.0 ± 179.8) as healthy controls (p < 0.01). However, immunization failed to protect mice against challenge with the virulent RH strain. There was a significant increase in T lymphocyte subclasses (CD3e+CD4+ T and CD3e+CD8a+ T lymphocytes) in splenic tissues in immunized mice compared with controls (p < 0.05). However, the level of antibodies, lymphocyte proliferation and concentration of cytokines (IFN-γ, IL-2, IL-4, IL-10 and IL-12p70) were not significantly different between immunized and control mouse groups (p < 0.05). These data indicate that pVAX1-HSP40 induced specific immune responses and achieved a significant reduction in the number of brain cysts in Pru-infected mice, and thus can be tested in future immunization studies along with plasmids containing other immunogenic proteins as a cocktail vaccine to fully abolish chronic toxoplasmosis.
first_indexed 2024-03-11T14:06:57Z
format Article
id doaj.art-2fd130ee96f941f298353ba6f509f0f5
institution Directory Open Access Journal
issn 1776-1042
language English
last_indexed 2024-03-11T14:06:57Z
publishDate 2018-01-01
publisher EDP Sciences
record_format Article
series Parasite
spelling doaj.art-2fd130ee96f941f298353ba6f509f0f52023-11-02T01:43:21ZengEDP SciencesParasite1776-10422018-01-01253710.1051/parasite/2018040parasite180052Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming miceLi Zhong-YuanLu JingZhang Nian-ZhangElsheikha Hany M.Hou Jun-LingGuo Hai-TingZhu Xing-QuanToxoplasma gondii causes one of the most common protozoal diseases of humans and animals worldwide. With the aim of designing an effective vaccine against T. gondii infection, we examined the immunogenicity of a DNA vaccine expressing heat shock protein 40 (HSP40) against challenge with T. gondii (type I RH and type II Pru) strains in Kunming mice. The plasmid pVAX1-HSP40 was constructed and used to immunize mice by intramuscular injection for three sequential immunizations with two-week intervals. This immunization regimen significantly reduced parasite cyst burden in pVAX1-HSP40-immunized mice (1871.9 ± 142.3) compared with control mouse groups immunized with pVAX1 (3479.2 ± 204.4), phosphate buffered saline (3024.4 ± 212.8), or left untreated (3275.0 ± 179.8) as healthy controls (p < 0.01). However, immunization failed to protect mice against challenge with the virulent RH strain. There was a significant increase in T lymphocyte subclasses (CD3e+CD4+ T and CD3e+CD8a+ T lymphocytes) in splenic tissues in immunized mice compared with controls (p < 0.05). However, the level of antibodies, lymphocyte proliferation and concentration of cytokines (IFN-γ, IL-2, IL-4, IL-10 and IL-12p70) were not significantly different between immunized and control mouse groups (p < 0.05). These data indicate that pVAX1-HSP40 induced specific immune responses and achieved a significant reduction in the number of brain cysts in Pru-infected mice, and thus can be tested in future immunization studies along with plasmids containing other immunogenic proteins as a cocktail vaccine to fully abolish chronic toxoplasmosis.https://doi.org/10.1051/parasite/2018040Toxoplasma gondiiHSP40DNA vaccineChronic infectionImmune evaluation
spellingShingle Li Zhong-Yuan
Lu Jing
Zhang Nian-Zhang
Elsheikha Hany M.
Hou Jun-Ling
Guo Hai-Ting
Zhu Xing-Quan
Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice
Parasite
Toxoplasma gondii
HSP40
DNA vaccine
Chronic infection
Immune evaluation
title Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice
title_full Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice
title_fullStr Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice
title_full_unstemmed Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice
title_short Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice
title_sort immunization with plasmid dna expressing heat shock protein 40 confers prophylactic protection against chronic toxoplasma gondii infection in kunming mice
topic Toxoplasma gondii
HSP40
DNA vaccine
Chronic infection
Immune evaluation
url https://doi.org/10.1051/parasite/2018040
work_keys_str_mv AT lizhongyuan immunizationwithplasmiddnaexpressingheatshockprotein40confersprophylacticprotectionagainstchronictoxoplasmagondiiinfectioninkunmingmice
AT lujing immunizationwithplasmiddnaexpressingheatshockprotein40confersprophylacticprotectionagainstchronictoxoplasmagondiiinfectioninkunmingmice
AT zhangnianzhang immunizationwithplasmiddnaexpressingheatshockprotein40confersprophylacticprotectionagainstchronictoxoplasmagondiiinfectioninkunmingmice
AT elsheikhahanym immunizationwithplasmiddnaexpressingheatshockprotein40confersprophylacticprotectionagainstchronictoxoplasmagondiiinfectioninkunmingmice
AT houjunling immunizationwithplasmiddnaexpressingheatshockprotein40confersprophylacticprotectionagainstchronictoxoplasmagondiiinfectioninkunmingmice
AT guohaiting immunizationwithplasmiddnaexpressingheatshockprotein40confersprophylacticprotectionagainstchronictoxoplasmagondiiinfectioninkunmingmice
AT zhuxingquan immunizationwithplasmiddnaexpressingheatshockprotein40confersprophylacticprotectionagainstchronictoxoplasmagondiiinfectioninkunmingmice